Fundz

Jaguar Health

SAN FRANCISCO, CA, United States · Healthcare, Health Care · 39 employees

Jaguar Health (NASDAQ: JAGX) (“Jaguar”) is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, sustainably derived prescription medicines for people and animals with GI distress, including chronic, debilitating diarrhea. Napo Pharmaceuticals, a Jaguar company, focuses on developing and commercializing proprietary human pharmaceuticals from plants harves

Funding history

  • Venture - Series Unknown — $40.8M — Jul 2026
  • Seed — $2.0M — Jul 2026
  • Venture - Series Unknown — $10.8M — Nov 2025
  • Seed — $1.0M — Oct 2025
  • Seed — $2.4M — Sep 2025

Recent signals

  • Jul 01, 2026: Raised $40.8M in Venture - Series Unknown
  • Jul 01, 2026: Raised $2.0M in Seed
  • May 19, 2026: Jaguar Health Enters into Series Q Preferred Stock Exchange Agreement
  • May 19, 2026: SEC 8-K (1.01): On May 19, 2026, Jaguar Health, Inc. entered into a material definitive agreement known as the Uptown Series Q Exchange Agreement with Uptown Capital, LLC. Under this agreement, the Company issued 500 shares of Series Q Perpetual Preferred Stock to Uptown in exchange for a $12,500,000 reduction in the outstanding balance of a previously established royalty interest of $12 million from December 22, 2020. This agreement aims to enhance the financial position of Jaguar Health by reducing the burden of its royalty payment obligations. The transaction effectively allows the Company to restructure its financing and potentially improve cash flow as the terms relate to royalty interest obligations are modified.
  • Dec 08, 2025: SEC 8-K (5.07): On December 8, 2025, Jaguar Health, Inc. held a special meeting of stockholders where three proposals were submitted and approved. A total of 747,205 shares of the Company’s common stock were voted, out of 3,735,835 shares entitled to vote. The proposals were detailed in the proxy statement filed with the SEC on November 10, 2025, reflecting changes or actions approved by the stockholders. This meeting is significant as it indicates shareholder engagement and approval of the company's key strategic decisions.
  • Nov 24, 2025: Raised $10.8M in Venture - Series Unknown
  • Oct 10, 2025: Raised $1.0M in Seed
  • Sep 23, 2025: Raised $2.4M in Seed

See plans & pricing → Track Jaguar Health’s funding, hiring, and signals — with verified contacts — on Fundz.